Milford life sciences company Waters Corp. has announced a new analytics system it says will impact the development of treatments and therapies for novel diseases.
The ACQUITY PREMIER Solution for liquid chromatography provides improved analytical data, according to a release from the company, and will reduce analysis time. It is also designed to eliminate surface interactions when analyzing substances such as organic acids and phosphopeptides by forming a barrier between what is being analyzed and metal surfaces during the analysis.
According to Waters, the new system increases detection sensitivity and assay-to-assay reproducibility.
